Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies
by
Giovannoni G, O'Sullivan JD,
Turner K, Manson AJ, Lees AJ.
Institute of Neurology,
Queen Square, London WC1N 3BG, UK.
G.Giovannoni@ion.ucl.ac.uk
J Neurol Neurosurg Psychiatry. 2000 Apr;68(4):423-8.


ABSTRACT

Hedonistic homeostatic dysregulation is a neuropsychological behavioural disorder associated with substance misuse and addiction. The disorder has been recognised as a consequence of dopamine replacement therapy (DRT) in 15 patients with Parkinson's disease. The syndrome typically develops in male patients with early onset Parkinson's disease, and can occur with orally and subcutaneously administered DRT. These patients take increasing quantities of their DRT, despite increasingly severe drug induced dyskinesias, and may develop a cyclical mood disorder with hypomania or manic psychosis. There is impairment of social and occupational functioning. Tolerance develops to mood elevating effects of DRT and a negative affective withdrawal state occurs if the drugs are withdrawn or doses decreased. The clinical features and guidelines for managing this syndrome are discussed. A set of diagnostic criteria for further investigating this condition is proposed.
Levodopa
Dopamine
Tolcapone
Rasagiline
GBR12909
Entacapone
Bromocriptine
Dopaminergics
Parkinson's disease: resources
Caffeine and Parkinson's disease
Depression in Parkinson's disease
Mianserin and Parkinson's disease
Selegiline and Parkinson's disease
Apomorphine and Parkinson's disease
Anticholinergics in Parkinson's disease
Parkinsonian signs/symptoms in depressives


Refs
and further reading

HOME
HedWeb
Nootropics
erythroxylum-coca.com
Future Opioids
BLTC Research
MDMA/Ecstasy
Superhapiness?
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Good Drug Guide

The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family